Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:53 UTC |
---|
HMDB ID | HMDB0015181 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Fluocinonide |
---|
Description | Fluocinonide is only found in individuals that have used or taken this drug. It is a topical glucocorticoid used in the treatment of eczema. [PubChem]Fluocinonide is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders such as eczema. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort. Fluocinonide binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. Cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Like other glucocorticoid agents Fluocinolone acetonide acts as a physiological antagonist to insulin by decreasing glycogenesis (formation of glycogen). It also promotes the breakdown of lipids (lipolysis), and proteins, leading to the mobilization of extrahepatic amino acids and ketone bodies. This leads to increased circulating glucose concentrations (in the blood). There is also decreased glycogen formation in the liver. |
---|
Structure | [H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Lidex | Kegg | Vanos | Kegg | Fluocinolide | HMDB | Fluocinolide acetate | HMDB | Fluocinolone acetonide acetate | HMDB | Fluocinonide emulsified base | HMDB | Bioglan brand OF fluocinonide | HMDB | FAPG, fluocinonide | HMDB | Fluocinolone acetonide 21 acetate | HMDB | Medicis brand OF fluocinonide | HMDB | Novoter | HMDB | Optimapharma brand OF fluocinonide | HMDB | Topsyn | HMDB | Acetonide 21-acetate, fluocinolone | HMDB | Clariana brand OF fluocinonide | HMDB | Fluocinolone acetonide 21-acetate | HMDB | Fluocinonide fapg | HMDB | Klariderm | HMDB | Lyderm | HMDB | Grünenthal brand OF fluocinonide | HMDB | Lidemol | HMDB | Syntex brand OF fluocinonide | HMDB | Tiamol | HMDB | Yamanouchi brand OF fluocinonide | HMDB | Metosyn | HMDB | Teofarma brand OF fluocinonide | HMDB | Topsym | HMDB | Topsyne | HMDB |
|
---|
Chemical Formula | C26H32F2O7 |
---|
Average Molecular Weight | 494.5249 |
---|
Monoisotopic Molecular Weight | 494.211609788 |
---|
IUPAC Name | 2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-8-yl]-2-oxoethyl acetate |
---|
Traditional Name | fluocinonide |
---|
CAS Registry Number | 356-12-7 |
---|
SMILES | [H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O |
---|
InChI Identifier | InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1 |
---|
InChI Key | WJOHZNCJWYWUJD-IUGZLZTKSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- 9-halo-steroid
- 6-halo-steroid
- Halo-steroid
- Hydroxysteroid
- Oxosteroid
- 11-beta-hydroxysteroid
- 11-hydroxysteroid
- Delta-1,4-steroid
- Ketal
- Alpha-acyloxy ketone
- Meta-dioxolane
- Cyclic alcohol
- Cyclic ketone
- Ketone
- Secondary alcohol
- Halohydrin
- Carboxylic acid ester
- Fluorohydrin
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Acetal
- Organic oxide
- Organic oxygen compound
- Alcohol
- Alkyl halide
- Carbonyl group
- Organohalogen compound
- Organofluoride
- Organooxygen compound
- Alkyl fluoride
- Hydrocarbon derivative
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 309 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.017 g/L | Not Available | LogP | 1.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Fluocinonide,1TMS,isomer #1 | CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3199.0 | Semi standard non polar | 33892256 | Fluocinonide,1TMS,isomer #2 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C | 3311.3 | Semi standard non polar | 33892256 | Fluocinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3249.1 | Semi standard non polar | 33892256 | Fluocinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3369.3 | Standard non polar | 33892256 | Fluocinonide,2TMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C)C[C@@]12C | 3721.3 | Standard polar | 33892256 | Fluocinonide,1TBDMS,isomer #1 | CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 3434.6 | Semi standard non polar | 33892256 | Fluocinonide,1TBDMS,isomer #2 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C | 3533.7 | Semi standard non polar | 33892256 | Fluocinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 3696.7 | Semi standard non polar | 33892256 | Fluocinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 3806.6 | Standard non polar | 33892256 | Fluocinonide,2TBDMS,isomer #1 | CC(=O)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]12C | 3863.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Fluocinonide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0005-2970300000-b28abd90df71a08d5830 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fluocinonide GC-MS (1 TMS) - 70eV, Positive | splash10-0uxv-8826190000-2fbadbdcb0a9e253ca76 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fluocinonide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluocinonide LC-ESI-qTof , Positive-QTOF | splash10-05p9-0489400000-cb64b15c0db3ac6d9647 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluocinonide , positive-QTOF | splash10-05p9-0489400000-cb64b15c0db3ac6d9647 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 10V, Positive-QTOF | splash10-002k-1000900000-e5fb75b78cc935feaae5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 20V, Positive-QTOF | splash10-000i-0131900000-536fef6403492e1fa2c6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 40V, Positive-QTOF | splash10-06vl-3090100000-1ba50606e9f8460db6f9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 10V, Negative-QTOF | splash10-052f-9004700000-80b0fde09a680751d47d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 20V, Negative-QTOF | splash10-0a4i-9001300000-af17f3d6e24dac3b4d87 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 40V, Negative-QTOF | splash10-0a4i-9103000000-dc678ae7667181f4963f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 10V, Positive-QTOF | splash10-002b-0002900000-e3fc2590054d37633c94 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 20V, Positive-QTOF | splash10-00mk-0011900000-363237e4357a441d0fa0 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 40V, Positive-QTOF | splash10-0006-2593700000-aa24051f16cec875596c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 10V, Negative-QTOF | splash10-052f-3000900000-ae14e057a2b93ea32666 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 20V, Negative-QTOF | splash10-0a4i-9000000000-c01bbbf5bed889264ddb | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluocinonide 40V, Negative-QTOF | splash10-0a4l-9300200000-d5906f7ea807d5bbb4d8 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|